Shane E. Cruz - 25 Apr 2022 Form 4 Insider Report for GoHealth, Inc. (GOCO)

Role: Chief Operating Officer
Signature: /s/ Brian Farley, Attorney-in-fact
Issuer symbol: GOCO
Transactions as of: 25 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 27 Apr 2022, 17:17:00 UTC
Previous filing: 15 Feb 2022
Next filing: 23 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GOCO	Class A Common Stock	Award	$0	+1,714,285	+1846%	$0.000000	1,807,128	25 Apr 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GOCO	Stock Option	Disposed to Issuer	$0	-77,602	-100%	$0.000000^*	0	25 Apr 2022	Class A Common Stock	77,602	$14.81	Direct	F2, F3
transaction	GOCO	Stock Option	Award	$0	+77,602		$0.000000	77,602	25 Apr 2022	Class A Common Stock	77,602	$1.05	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest in three equal annual installments, with the first such annual installment vesting on April 25, 2023.
F2	The stock option vests in three equal annual installments, with the first such installment vesting on February 11, 2022.
F3	In accordance with the terms of the GoHealth, Inc. 2020 Incentive Award Plan, the Board of Directors of GoHealth, Inc. approved a stock option repricing pursuant to which option awards were amended to reduce the exercise price to $1.05 per share.